Test your knowledge of ERBB2 mutation in HER2-nonamplified breast cancer

ERBB2 mutations are the same as HER2 amplification.
True
False
Which combination therapy demonstrated clinical benefit in patients with estrogen receptor–positive HER2-nonamplified metastatic breast cancer with ERBB2 mutations in the phase II MutHER trial?
Goserelin, letrozole, and denosumab
Palbociclib and fulvestrant
Letrozole and alpelisib
Neratinib and fulvestrant
When starting neratinib with a 2-week dose escalation, patients should start at which dose for the first week?
120 mg
60 mg
240 mg
{"name":"Test your knowledge of ERBB2 mutation in HER2-nonamplified breast cancer", "url":"https://www.quiz-maker.com/Q0XY5JN5R","txt":"ERBB2 mutations are the same as HER2 amplification., Which combination therapy demonstrated clinical benefit in patients with estrogen receptor–positive HER2-nonamplified metastatic breast cancer with ERBB2 mutations in the phase II MutHER trial?, When starting neratinib with a 2-week dose escalation, patients should start at which dose for the first week?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}
Powered by: Quiz Maker